Technology
BIV's coverage delves into all issues affecting tech businesses in Vancouver and British Columbia
Securities regulator grapples with fintech innovations
Complications arise when new finance technology meets current securities regulations
How vaccine distribution is taking shape amid manufacturing hiccups, remote deliveries
Ottawa says Canada still set to receive four million doses by March even as Pfizer faces production issues
Rogers rolls out first 5G standalone core in Vancouver, expands B.C. coverage
Rogers Communications Inc. (TSX:RCI.B) is rolling out the first 5G standalone core in Canada, with Vancouver among four cities that will be able to eventually tap into the new infrastructure. The...
From keeping cool to prioritizing people, how B.C. businesses are supporting vaccine rollout
B.C. companies are stepping up to assist with the rollout of the vaccine
AbCellera’s market value hits US$15.7b after first day of trading
Vancouver biotech known for its work on a COVID-19 treatment
Beware – Santa could bring home cybersecurity risks
Proliferation of home high-tech gadgets could expose personal data to crooks
AbCellera IPO: Shares surge more than 250% upon debut (UPDATED)
Trading held at the opening of markets
AbCellera boosts IPO target second time in a week, seeks to raise US$483m
The B.C. biotech firm instrumental in the development of a COVID-19 treatment has boosted its ambitions for an initial public offering for the second time in a week. AbCellera Biologics Inc....
Boast.AI raises $30m as B.C. tech firm hones in on R&D tax credits for others
Vancouver company plans to boost its headcount following close of Series A funding round
B.C. biotech in the spotlight after Health Canada approves Pfizer-BioNTech vaccine
Vancouver-based Acuitas Therapeutics played key role in vaccine's development